Left ventricular assist device: Difference between revisions
Jump to navigation
Jump to search
imported>Fergus Dixon (LVAD) |
imported>Bruce M. Tindall mNo edit summary |
||
Line 1: | Line 1: | ||
{{subpages}} | |||
Left Ventricular Assist Device or LVAD | Left Ventricular Assist Device or LVAD | ||
Revision as of 15:14, 7 February 2009
Left Ventricular Assist Device or LVAD
A Left Ventricular Assist Device is a pump which runs in parallel with a heart to boost the blood flow. The main reason for a patient to have a LVAD implanted is for Bridge To Transplant (BTT) or Destination Therapy (DT). Currently, the top three companies in this field are: 1. Thoratec - Heartmate2 market capital $2B US 2. Ventracor - VentrAssist 3. Heartware